Items in cart [1] Questions? Call 888-624-8373

PAPERBACK list:$20.00 Web:$18.00 add to cart PDF BOOK your price: $15.50 add to cart Rights & Permissions Free Resources PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles From Cancer Patient to Cancer Survivor: Lost in Transition Strategies to Leverage Research Funding: Guiding DOD's Peer Reviewed Medical Research Programs Other Related Titles A Review of the Department of Defense's Program for Breast Cancer Research (1997) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 117   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. APPENDIX C ''Dear Colleague" Letter INSTITUTE OF MEDICINE NATIONAL ACADEMY OF SCIENCES 2101 CONSTITUTION AVENUE, N.W. WASHINGTON, D.C. 20418 COMMITTEE ON BREAST CANCER RESEARCH PHONE (202) 334-1917 FAX (202) 334-2316 October 18, 1996 Dear Colleague, As you know, Congress has allocated well over $400 million to the Department of Defense (DOD) since 1993 and designated the U.S. Army Medical Research and Materiel Command to oversee the Breast Cancer Research Program. This program is currently being reviewed and evaluated by an independent scientific committee appointed by the Institute of Medicine (IOM). An important part of this process is gathering information about scientists' experiences as grant applicants and, subsequently, as grantees. We are inviting you to comment on the DOD's implementation of this grant program. Please feel free to comment on: (1) specific aspects of the program (e.g., procedures for proposal submission, peer review, budgetary review and tracking, protection of study participants, and project oversight), and (2) the program overall. Please submit your comments anonymously. For your convenience, we have provided a return label. Page 117 Front Matter (R1-R15) Executive Summary (1-16) 1 Introduction (17-21) 2 Breast Cancer: Biology and Medicine (22-32) 3 Non-BCRP Support for Breast Cancer Research (33-44) 4 U.S. Army Breast Cancer Research Program (45-64) 5 The Funded Portfolio of the 1993/1994 and 1995 BCRP Award Cycles (65-85) 6 Critique (86-96) 7 Conclusions and Recommendations (97-106) References (107-112) Appendix A: Individuals Who Provided Testimony to the Committee (113-115) Appendix B: Individuals Who Provided Written Response to Committee Questions (116-116) Appendix C: Dear Colleague Letter (117-118) Appendix D: Responses to Dear Colleague Letter (119-120) Appendix E: Tissue Bank Letter and Questionnaire (121-124) Glossary and Acronyms (125-130) Biographical Sketches (131-136)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 117
A Review of the Department of Defense's Program for Breast Cancer Research APPENDIX C ''Dear Colleague" Letter INSTITUTE OF MEDICINE NATIONAL ACADEMY OF SCIENCES 2101 CONSTITUTION AVENUE, N.W. WASHINGTON, D.C. 20418 COMMITTEE ON BREAST CANCER RESEARCH PHONE (202) 334-1917 FAX (202) 334-2316 October 18, 1996 Dear Colleague, As you know, Congress has allocated well over $400 million to the Department of Defense (DOD) since 1993 and designated the U.S. Army Medical Research and Materiel Command to oversee the Breast Cancer Research Program. This program is currently being reviewed and evaluated by an independent scientific committee appointed by the Institute of Medicine (IOM). An important part of this process is gathering information about scientists' experiences as grant applicants and, subsequently, as grantees. We are inviting you to comment on the DOD's implementation of this grant program. Please feel free to comment on: (1) specific aspects of the program (e.g., procedures for proposal submission, peer review, budgetary review and tracking, protection of study participants, and project oversight), and (2) the program overall. Please submit your comments anonymously. For your convenience, we have provided a return label.

OCR for page 118
A Review of the Department of Defense's Program for Breast Cancer Research The grantees' perspective will play an important part in the committee's deliberations. Please limit your comments to two pages. Because of the short time frame for this study, we need to receive your responses no later than November 1, 1996. We encourage you to fax your response to 202-334-2316. We appreciate you cooperation. Sincerely, Mary Poos Study Director Committee on Breast Cancer Research Sincerely, George Davatelis Program Officer Committee on Breast Cancer Research

Representative terms from entire chapter:

cancer research